Suspension of trading

Valuation Numinus Wellness Inc. Toronto S.E.

Equities

Delayed Toronto S.E. Other stock markets 11:00:00 2026-01-21 am EST			5-day change	1st Jan Change
0.0500 ^CAD	-.--%		-.--%	-

Data adjusted to current consolidation scope

Fiscal Period: August	2020	2021	2022	2023	2024
Capitalization ¹	22.97	175.3	91.27	52.55	10.25
Change	-	663.08%	-47.92%	-42.42%	-80.49%
Enterprise Value (EV) ¹	21.76	117.6	66.08	51.17	10.33
Change	-	440.46%	-43.8%	-22.55%	-79.82%
P/E ratio	-1.6x	-7.59x	-2.03x	-1.72x	-0.48x
PBR	8.22x	2.88x	2.21x	3.74x	14.1x
PEG	-0x	0.3x	-0x	0x	0x
Capitalization / Revenue	26.1x	116x	14.1x	2.27x	2.46x
EV / Revenue	24.7x	77.7x	10.2x	2.21x	2.48x
EV / EBITDA	-3.18x	-7.6x	-2.37x	-2.01x	-0.9x
EV / EBIT	-2.99x	-7.42x	-2.32x	-1.94x	-0.87x
EV / FCF	-8.45x	-12.9x	-4.69x	-3.91x	-1.76x
FCF Yield	-11.8%	-7.75%	-21.3%	-25.6%	-56.7%
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-0.1504	-0.1138	-0.1752	-0.1148	-0.0666
Distribution rate	-	-	-	-	-
Net sales ¹	0.8812	1.514	6.494	23.18	4.168
EBITDA ¹	-6.84	-15.47	-27.88	-25.4	-11.44
EBIT ¹	-7.282	-15.84	-28.45	-26.4	-11.92
Net income ¹	-9.601	-18.77	-44.88	-30.26	-19.64
Net Debt ¹	-1.213	-57.69	-25.19	-1.38	0.0743
Reference price ²	0.2401	0.8634	0.3562	0.1972	0.0320
Nbr of stocks (in thousands)	95,651	202,988	256,237	266,455	320,552
Announcement Date	12/29/20	12/9/21	11/29/22	11/29/23	7/25/25

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LONZA GROUP AG	29.29x	5.17x	16.01x	1.11%	43.39B
BEONE MEDICINES AG	47.3x	4.79x	31.52x	-.--%	34.7B
REVOLUTION MEDICINES, INC.	-17.93x	275.37x	-16.05x	-.--%	30.15B
IQVIA HOLDINGS INC.	21.76x	2.53x	10.94x	-.--%	29.83B
CELLTRION, INC.	31.98x	8.16x	20.99x	0.39%	28.46B
IONIS PHARMACEUTICALS, INC.	-21.32x	13.76x	-21.38x	-.--%	12.51B
EUROFINS SCIENTIFIC SE	20.79x	1.84x	8.08x	1.29%	12.29B
Average	15.98x	44.52x	7.16x	0.4%	27.33B
Weighted average by Cap.	20.49x	48.06x	10.77x	0.39%